Rock Creek Group’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-150
| Closed | -$147K | – | 230 |
|
|
2021
Q3 | $147K | Sell |
150
-339
| -69% | -$332K | 0.02% | 120 |
|
|
2021
Q2 | $731K | Buy |
489
+67
| +16% | +$100K | 0.11% | 75 |
|
|
2021
Q1 | $1.14M | Sell |
422
-256
| -38% | -$689K | 0.19% | 59 |
|
|
2020
Q4 | $1.34M | Buy |
678
+104
| +18% | +$205K | 0.55% | 51 |
|
|
2020
Q3 | $1.55M | Buy |
574
+218
| +61% | +$588K | 0.8% | 35 |
|
|
2020
Q2 | $1.01M | Sell |
356
-177
| -33% | -$502K | 0.54% | 43 |
|
|
2020
Q1 | $1.43M | Buy |
533
+276
| +107% | +$738K | 0.79% | 39 |
|
|
2019
Q4 | $655K | Buy |
257
+57
| +29% | +$145K | 0.26% | 84 |
|
|
2019
Q3 | $187K | Sell |
200
-17
| -8% | -$15.9K | 0.09% | 101 |
|
|
2019
Q2 | $255K | Buy |
+217
| New | +$255K | 0.12% | 100 |
|